| Item Type | Name |
|
Concept
|
Chromosomes, Human, X
|
|
Concept
|
Humans
|
|
Concept
|
Chromosomes, Human
|
|
Concept
|
Chromosomes, Human, Pair 1
|
|
Concept
|
Nontherapeutic Human Experimentation
|
|
Concept
|
Chromosomes, Human, Pair 10
|
|
Concept
|
Chromosomes, Human, Pair 6
|
|
Academic Article
|
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
|
|
Academic Article
|
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
|
|
Academic Article
|
Missing pieces in the Parkinson's disease puzzle.
|
|
Academic Article
|
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
|
|
Academic Article
|
Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects.
|
|
Academic Article
|
Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.
|
|
Academic Article
|
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
|
|
Academic Article
|
Association between antipsychotics and body mass index when treating patients with tics.
|
|
Academic Article
|
An update expert opinion on management and research strategies in Parkinson's disease psychosis.
|
|
Academic Article
|
I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging.
|
|
Academic Article
|
Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
|
|
Academic Article
|
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia.
|
|
Academic Article
|
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
|
|
Academic Article
|
Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations.
|
|
Academic Article
|
Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease.
|
|
Academic Article
|
Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
|
|
Academic Article
|
Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
|
|
Academic Article
|
Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing.
|
|
Academic Article
|
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
|
|
Academic Article
|
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
|
|
Academic Article
|
Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
|
|
Academic Article
|
Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
|
|
Academic Article
|
Neuropathic features in fragile X premutation carriers.
|
|
Academic Article
|
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
|
|
Academic Article
|
Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor.
|
|
Academic Article
|
Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders.
|
|
Academic Article
|
The malignant course of "benign hallucinations" in Parkinson disease.
|
|
Academic Article
|
Determinants of quality of life in children with Gilles de la Tourette syndrome.
|
|
Academic Article
|
Movement disorders caused by medical disease.
|
|
Academic Article
|
Coping strategies for visual hallucinations in Parkinson's disease.
|
|
Academic Article
|
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
|
|
Academic Article
|
Pierre Marie: gifted intellect, poor timing and unchecked emotionality.
|
|
Academic Article
|
Wheeled and standard walkers in Parkinson's disease patients with gait freezing.
|
|
Academic Article
|
Impact of placebo assignment in clinical trials of Parkinson's disease.
|
|
Academic Article
|
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
|
|
Academic Article
|
Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program.
|
|
Academic Article
|
Re: UPDRS: Status and recommendations.
|
|
Academic Article
|
Medical-legal issues in Charcot's neurologic career.
|
|
Academic Article
|
The origins of scientific cinematography and early medical applications.
|
|
Academic Article
|
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
|
|
Academic Article
|
Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape.
|
|
Academic Article
|
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model.
|
|
Academic Article
|
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation.
|
|
Academic Article
|
Movement disorders: understanding clinical trials.
|
|
Academic Article
|
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.
|
|
Academic Article
|
Hallucinations and sleep disorders in PD: six-year prospective longitudinal study.
|
|
Academic Article
|
A responsive outcome for Parkinson's disease neuroprotection futility studies.
|
|
Academic Article
|
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
|
|
Academic Article
|
Transcultural comparison of psychogenic movement disorders.
|
|
Academic Article
|
Rating scale for psychogenic movement disorders: scale development and clinimetric testing.
|
|
Academic Article
|
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
|
|
Academic Article
|
Movement disorders associated with encephalitis lethargica: a video compilation.
|
|
Academic Article
|
Hallucinations in Parkinson disease in the prelevodopa era.
|
|
Academic Article
|
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials.
|
|
Academic Article
|
Charcot in contemporary literature.
|
|
Academic Article
|
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
|
|
Academic Article
|
Does seasonal variation affect hallucinations in PD? A longitudinal study.
|
|
Academic Article
|
Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
|
|
Academic Article
|
Early cinematographic studies of generalized dystonia.
|
|
Academic Article
|
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
|
|
Academic Article
|
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
|
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
|
|
Academic Article
|
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
|
|
Academic Article
|
Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
|
|
Academic Article
|
Depression rating scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.
|
|
Academic Article
|
Levodopa-induced dyskinesias.
|
|
Academic Article
|
Contribution of Jules Froment to the study of parkinsonian rigidity.
|
|
Academic Article
|
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
|
|
Academic Article
|
J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies.
|
|
Academic Article
|
Disclosure on author work effort.
|
|
Academic Article
|
Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies.
|
|
Academic Article
|
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
|
|
Academic Article
|
Placebo influences on dyskinesia in Parkinson's disease.
|
|
Academic Article
|
Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
|
|
Academic Article
|
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
|
|
Academic Article
|
Concerning about the accuracy of data reported.
|
|
Academic Article
|
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
|
|
Academic Article
|
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
|
|
Academic Article
|
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening.
|
|
Academic Article
|
Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.
|
|
Academic Article
|
Anxiety rating scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Comparison of tic characteristics between children and adults.
|
|
Academic Article
|
The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
|
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
|
|
Academic Article
|
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device.
|
|
Academic Article
|
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
|
|
Academic Article
|
Teaching program for the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Hallucinations in Parkinson disease.
|
|
Academic Article
|
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
|
|
Academic Article
|
Jean-Martin Charcot and his vibratory chair for Parkinson disease.
|
|
Academic Article
|
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
|
|
Academic Article
|
Fibroblast phenotype in male carriers of FMR1 premutation alleles.
|
|
Academic Article
|
Chapter 15: Jean-Martin Charcot and the anatomo-clinical method of neurology.
|
|
Academic Article
|
Scales to evaluate psychosis in Parkinson's disease.
|
|
Academic Article
|
Charcot and Pasteur: intersecting orbits in fin de si?cle French medicine.
|
|
Academic Article
|
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.
|
|
Academic Article
|
Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor.
|
|
Academic Article
|
Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
|
|
Academic Article
|
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
|
|
Academic Article
|
A 12-year population-based study of psychosis in Parkinson disease.
|
|
Academic Article
|
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study.
|
|
Academic Article
|
Priorities in Parkinson's disease research.
|
|
Academic Article
|
The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.
|
|
Academic Article
|
The movement disorder society and movement disorders: a modern history.
|
|
Academic Article
|
Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.
|
|
Academic Article
|
Wearing-off scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Temporal stability of the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
|
|
Academic Article
|
Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.
|
|
Academic Article
|
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
|
|
Academic Article
|
The history of Parkinson's disease: early clinical descriptions and neurological therapies.
|
|
Academic Article
|
Tai chi for patients with Parkinson's disease.
|
|
Academic Article
|
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations.
|
|
Academic Article
|
Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
|
|
Academic Article
|
Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.
|
|
Academic Article
|
Which dyskinesia scale best detects treatment response?
|
|
Academic Article
|
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
|
|
Academic Article
|
The Parkinson's disease multidisciplinary package.
|
|
Academic Article
|
Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
|
|
Academic Article
|
Treating melancholia at home: theoretical wisdom and grim reality in the career of E.C. Seguin.
|
|
Academic Article
|
The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.
|
|
Academic Article
|
Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.
|
|
Academic Article
|
Dystonia rating scales: critique and recommendations.
|
|
Academic Article
|
Vibration therapy for Parkinson's disease: Charcot's studies revisited.
|
|
Academic Article
|
Task force report: scales for screening and evaluating tremor: critique and recommendations.
|
|
Academic Article
|
Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
|
|
Academic Article
|
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
|
|
Academic Article
|
A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.
|
|
Academic Article
|
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.
|
|
Academic Article
|
Are patients with Parkinson's disease blind to blindsight?
|
|
Academic Article
|
The past, present, and future of telemedicine for Parkinson's disease.
|
|
Academic Article
|
Maynard M. Cohen, MD, PhD (1920-2014).
|
|
Academic Article
|
Initial management of Parkinson's disease.
|
|
Academic Article
|
Handling missing values in the MDS-UPDRS.
|
|
Academic Article
|
MDS clinical diagnostic criteria for Parkinson's disease.
|
|
Academic Article
|
MDS research criteria for prodromal Parkinson's disease.
|
|
Academic Article
|
Clinimetric testing of the comprehensive cervical dystonia rating scale.
|
|
Academic Article
|
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
|
|
Academic Article
|
Age at onset in two common neurodegenerative diseases is genetically controlled.
|
|
Academic Article
|
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
|
|
Academic Article
|
Treatment interventions for Parkinson's disease: an evidence based assessment.
|
|
Academic Article
|
Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
|
|
Academic Article
|
Jean-Martin Charcot and the aging brain.
|
|
Academic Article
|
Treatment of advanced Parkinson's disease: an evidence-based analysis.
|
|
Academic Article
|
History of the extensor plantar response: Babinski and Chaddock signs.
|
|
Academic Article
|
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.
|
|
Academic Article
|
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
|
|
Academic Article
|
Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
|
|
Academic Article
|
The prefaces by Charcot: leitmotifs of an international career.
|
|
Academic Article
|
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.
|
|
Academic Article
|
Tremor and ataxia in fragile X premutation carriers: blinded videotape study.
|
|
Academic Article
|
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
|
|
Academic Article
|
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
|
|
Academic Article
|
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
|
|
Academic Article
|
Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale.
|
|
Academic Article
|
Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations".
|
|
Academic Article
|
Differential item functioning in the Unified Dyskinesia Rating Scale (UDysRS).
|
|
Academic Article
|
Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Closing the celebration of 200 years of Parkinson's Essay on the Shaking Palsy: Where do we go in the next 200 years?
|
|
Academic Article
|
Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.
|
|
Academic Article
|
Validation study of the hoehn and yahr scale included in the MDS-UPDRS.
|
|
Academic Article
|
Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study.
|
|
Academic Article
|
Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect.
|
|
Academic Article
|
Telemedicine Use for Movement Disorders: A Global Survey.
|
|
Academic Article
|
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.
|
|
Academic Article
|
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.
|
|
Academic Article
|
What influences placebo and nocebo responses in Parkinson's disease?
|
|
Academic Article
|
Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
|
|
Academic Article
|
Movement disorder society criteria for clinically established early Parkinson's disease.
|
|
Academic Article
|
Reply: Hoehn and Yahr stage 3 and Postural stability item in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Parkinson's disease: Is it a consequence of human brain evolution?
|
|
Academic Article
|
The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.
|
|
Academic Article
|
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
|
|
Academic Article
|
Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-duration.
|
|
Academic Article
|
The Progressive Supranuclear Palsy Clinical Deficits Scale.
|
|
Academic Article
|
Postural Directionality and Head Tremor in Cervical Dystonia.
|
|
Academic Article
|
Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era.
|
|
Academic Article
|
The Mini-OAKHQOL for knee and hip osteoarthritis quality of life was obtained following recent shortening guidelines.
|
|
Academic Article
|
Visibility and Depth of the Stromal Demarcation Line After Corneal Collagen Cross-Linking Using Anterior Segment Optical Coherence Tomography: Comparison Between Isoosmolar and Hypoosmolar Riboflavin.
|
|
Academic Article
|
Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items.
|
|
Academic Article
|
The Evolution-Driven Signature of Parkinson's Disease.
|
|
Academic Article
|
Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
|
|
Academic Article
|
Efficacy, tolerability, and safety of an innovative medical device for improving oral accessibility during oral examination in special-needs patients: A multicentric clinical trial.
|
|
Academic Article
|
Apathy in Parkinson disease: Why we should care.
|
|
Academic Article
|
It's tricky: Rating alleviating maneuvers in cervical dystonia.
|
|
Academic Article
|
Head tremor and pain in cervical dystonia.
|
|
Academic Article
|
In Support of Electronic Versions of Movement Disorder Society Rating Scales.
|
|
Academic Article
|
COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?
|
|
Academic Article
|
Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS).
|
|
Academic Article
|
Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?
|
|
Academic Article
|
Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia?
|
|
Academic Article
|
Validation of the Finnish Version of the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change.
|
|
Academic Article
|
Rating scales for medication adherence in people living with Parkinson's disease: a systematic review protocol.
|
|
Academic Article
|
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
|
|
Academic Article
|
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
|
|
Academic Article
|
Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Implementation and Outcomes of a Movement Disorder Society-Sponsored Peer Reviewing Education and Mentoring Program.
|
|
Academic Article
|
Two faces of the teacher: Comparing editions of Charcot's Le?ons du mardi.
|
|
Academic Article
|
Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1.
|
|
Academic Article
|
Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
|
|
Academic Article
|
Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease.
|
|
Academic Article
|
Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine.
|
|
Academic Article
|
Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis.
|
|
Academic Article
|
It Is as It Was: MDS-UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum.
|
|
Academic Article
|
Reply to: Comment on "Summing MDS-UPDRS Parts 1?+?2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice".
|
|
Academic Article
|
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.
|
|
Academic Article
|
Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.
|
|
Academic Article
|
Cross-Cultural Differences in Patient Perceptions of Dyskinesia in Parkinson's Disease.
|
|
Academic Article
|
The plight of loneliness in Parkinson's disease: New opportunities.
|
|
Academic Article
|
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants.
|
|
Academic Article
|
Summing MDS-UPDRS Parts 1?+?2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice.
|
|
Academic Article
|
Understanding visual hallucinations: A new synthesis.
|
|
Academic Article
|
A Unified Framework for Evidence-Based Diagnostic Criteria Programs in Movement Disorders.
|